Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Cyclophosphamide 416 Radiotherapy 276 fludarabine 238 Gemcitabine 211 Cisplatin 203 Nivolumab 184 pembrolizumab 183 Paclitaxel 176 Carboplatin 168 Magnetic Resonance Spectroscopy 167 fludarabine phosphate 156 Irinotecan 135 Bevacizumab 133 Cytarabine 128 Specimen Handling 125 Capecitabine 124 Temozolomide 123 Radiosurgery 118 Biopsy 117 Docetaxel 116 Dexamethasone 113 Ipilimumab 112 Radiation 111 Oxaliplatin 110 Fluorouracil 110 Rituximab 108 Etoposide 108 Filgrastim 99 Lenalidomide 98 Everolimus 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × lirilumab × Clear all

NCT03532451 2024-09-19

PrE0807

PrECOG, LLC.

Phase 1 Completed

43 enrolled 15 charts

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡